SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹42 Cr | ₹1,251,750 Cr | ₹8.74 Cr | ₹8.74 Cr |
What is the latest Operating Profit of SHREE GANESH REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹1,251,750 Cr |
| Mar2020 | ₹8.74 Cr |
| Mar2019 | ₹8.74 Cr |
How is Operating Profit of SHREE GANESH REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | -100.00 | |
| Mar2024 | ₹1,251,750 Cr | 14,317,065.25 | |
| Mar2020 | ₹8.74 Cr | 0.00 | |
| Mar2019 | ₹8.74 Cr | - | |
Compare Operating Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹835.8 Cr | -2.8% | 2.3% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.8% |
2.3% |
9.4% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses